IP Library Granted Patent US 11,499,137
Granted Patent B2
US 11,499,137 · App. 16/143,112 · Granted Nov 15, 2022

Induction of hemogenic endothelium from pluripotent stem cells by forced expression of transcription factors

Inventors: Igor Slukvin (Verona, WI); Irina Elcheva (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N5/0606C12N5/0608C12N5/0647C12N15/00C12N15/11C12N15/66C12N2501/60C12N2501/998C12N2506/02C12N2506/45C12N2510/00C12N2740/16043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,499,137
App. No.
16/143,112
Granted
Nov 15, 2022
Kind
B2
Abstract

Described herein are methods and related compositions for inducing differentiation of human pluripotent stem cells (hPSCs) into hemogenic endothelium with pan-myeloid potential or restricted potential, by forced expression in the hPSCs of a combination of transcription factors as described herein.

Claims (6)

1. A method for generating human hemogenic endothelial cells with restricted erythroid, megakaryocytic, and macrophage potential, comprising

(i) introducing exogenous TAL1 protein and GATA1 protein or exogenous expression cassettes comprising nucleic acids encoding TAL1 and GATA1 in human pluripotent stem cells, and

(ii) culturing the human pluripotent stem cells following step (i), under culture conditions that support expansion of hematopoietic cells, to obtain hemogenic endothelial cells that are VE-cadherin + , CD226 + , CD73 − , and have restricted erythroid, megakaryocytic, and macrophage potential.

2. The method of claim 1 , wherein induced protein or nucleic acid expression does not comprise expression of LMO2.

3. The method of claim 1 , further comprising culturing the hemogenic endothelial cells for an additional period to obtain erythrocytes, megakaryocytes, or macrophages.

4. The method of claim 1 , further comprising the introduction of exogenous LMO2 protein or exogenous expression cassettes comprising nucleic acids encoding nucleic acid encoding LMO2 in the human pluripotent stem cells to induce differentiation into erythrocytes, megakaryocytes and macrophages.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2018
From: SLUKVIN, IGOR; ELCHEVA, IRINA
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 046991/0661 →
Continuity (5)
Division 15684647 · Aug 23, 2017
Division 15183191 · Jun 15, 2016
Division 14058959 · Oct 21, 2013
Provisional Application 61716875 · Oct 22, 2012
Related Publication 20190144823A1 · May 16, 2019